Treatment of electronic cigarette or vaping product use‐associated lung injury (EVALI) by corticosteroid and low‐dose pirfenidone: Report of a case

Electronic (e)‐cigarette or vaping product use‐associated lung injury (EVALI) is a novel and potentially lethal disease first reported in the United States. We report the case of a 56‐year‐old man who presented to our hospital with dyspnoea and cough lasting for 2 months after using an e‐cigarette f...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chia‐Hao, Liao, Ting‐Yu, Chen, Yung‐Hsuan, Kuo, Ping‐Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453260/
https://www.ncbi.nlm.nih.gov/pubmed/34584727
http://dx.doi.org/10.1002/rcr2.845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453260/
https://www.ncbi.nlm.nih.gov/pubmed/34584727
http://dx.doi.org/10.1002/rcr2.845

Ejemplares similares